Amgen

Open: 271.17 Close: 269.12 Change: -2.05

Are you looking for information about Amgen Stock? We programmed an AI to summarize it for you.

This document will help you to evaluate Amgen without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Amgen are: Amgen, Horizon, Therapeutics, shareholder, dividend, company, US, and the …

Concept Map

Semantic Network

Stock Summary

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's products include Enbrel, Prolia, Xgeva, Otezla, Aranesp, and Repatha..

Today's Summary

Amgen (NASDAQ:AMGN) shareholders have earned a 9.8% share. Amgen acquired Horizon Therapeutics last month. Federal Circuit demanded full scope enablement in biological and chemical fields before Amgen.

Today's News

Amgen acquired Horizon Therapeutics last month. New rare disease business line unveiled during companys third quarter earnings teleconference call. The Federal Circuit demanded full scope enablement in biological and chemical fields before Amgen. Some experts believe Amgen expanded the requirement. Amgen shareholders are down 2.5% for the year (even including dividends), but the market itself is up 17%. Amgen (NASDAQ:AMGN) shareholders have earned a 9.8%. Amgen is listed as having around 500 people on LinkedIn. The company is headquartered in Thousand Oaks, California, US. Amgen sells products primarily to pharmaceutical wholesale distributors in the US. Amgen is an Equal Opportunity employer and will consider you without regard to your race, color, religion, sex, sex. and gender identity, national origin, protected veteran status, or disability status. Amgen Rhode Island has created a diversity, inclusion and belonging talent council. Amgen operates under the concept that its diverse workforce reflects its diverse customer base. Part I examines how scholars and attorneys have reacted to Amgen , focusing on whether they think the case will have a legal and practical impact. Part II synthesizes these perspectives, arguing that Amgen s direct impact will be. Amgen has an annual dividend of $8.52 per share, with a forward yield of 3.17%. The boeing company vs. amgen: With return forecast of 11%, The Boeing Company Is A Better Bet. Amgen to work on generative AI solutions to advance therapies. James Comer probes FTC conduct in Amgens takeover of Horizon Therapeutics. Elizabeth Warren tells FTC she remains concerned about Amgen Horizon deal.

Stock Profile

"Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; and Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization. It also markets Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. It has collaboration agreements with Novartis Pharma AG; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; Eli Lilly and Company; Datos Health; and Verastem, Inc. to evaluate VS-6766 in combination with lumakrastm (Sotorasib) in patients with KRAS G12C-mutant non-small cell lung cancer. It has an agreement with Kyowa Kirin Co., Ltd. to jointly develop and commercialize KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody for the treatment of atopic dermatitis and other autoimmune diseases; and research and development collaboration with Neumora Therapeutics, Inc. and Plexium, Inc. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California."

Keywords

How much time have you spent trying to decide whether investing in Amgen? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Amgen are: Amgen, Horizon, Therapeutics, shareholder, dividend, company, US, and the most common words in the summary are: amgen, news, job, release, drug, press, new, . One of the sentences in the summary was: Amgen (NASDAQ:AMGN) shareholders have earned a 9.8% share. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #amgen #news #job #release #drug #press #new.